|
gptkbp:instanceOf
|
gptkb:COVID-19
|
|
gptkbp:alsoKnownAs
|
gptkb:Omicron_BA.2
|
|
gptkbp:associatedWith
|
gptkb:COVID-19_pandemic
|
|
gptkbp:detects
|
PCR test
genomic sequencing
|
|
gptkbp:discoveredBy
|
gptkb:South_Africa
November 2021
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
BA.2 variant
|
|
gptkbp:immuneEvasion
|
increased compared to previous variants
|
|
gptkbp:impactOnVaccineEfficacy
|
reduced but still effective
|
|
gptkbp:mutationAssociatedWith
|
gptkb:S:P681H
S:D614G
S:N501Y
S:T478K
S:E484A
S:L452R
|
|
gptkbp:nickname
|
stealth Omicron
|
|
gptkbp:notableFeature
|
lacks S-gene target failure (SGTF) mutation
|
|
gptkbp:PangoLineage
|
gptkb:BA.2
|
|
gptkbp:prevalence
|
high in early 2022
|
|
gptkbp:relatedTo
|
BA.1 variant
BA.3 variant
BA.4 variant
BA.5 variant
|
|
gptkbp:relativeTransmissibility
|
higher than BA.1
|
|
gptkbp:spreadRapidlyIn
|
gptkb:Asia
gptkb:Europe
gptkb:United_States
|
|
gptkbp:subclassOf
|
gptkb:Omicron_variant
|
|
gptkbp:symptomsSimilarTo
|
BA.1 variant
|
|
gptkbp:WHOClassification
|
gptkb:Variant_of_Concern
|
|
gptkbp:bfsParent
|
gptkb:COVID-19
|
|
gptkbp:bfsLayer
|
4
|